Literature DB >> 31996918

The Detection of Serum IgMs to Thyroglobulin in Subacute Thyroiditis Suggests a Protective Role of IgMs in Thyroid Autoimmunity.

Debora Ricci1, Alessandro Brancatella1, Michele Marinò1, Mario Rotondi2, Luca Chiovato2, Paolo Vitti1, Francesco Latrofa1.   

Abstract

CONTEXT: The role of serum immunoglobulin (Ig)Ms in autoimmune thyroid diseases is uncertain.
OBJECTIVE: We looked for IgMs to thyroglobulin (Tg) in patients with subacute thyroiditis (SAT), which is characterized by high serum Tg levels, the possible de novo appearance of IgGs to Tg (TgAb-IgGs), and no autoimmune sequelae. MAIN OUTCOME MEASURES: TgAb-IgMs and TgAb-IgGs were detected by binding to Tg using the enzyme-linked immunosorbent assay (ELISA). The upper reference limit of TgAb-IgMs and TgAb-IgGs was established in 40 normal subjects. We looked for TgAb-IgMs in 16 patients with SAT, 11 with Hashimoto's thyroiditis (HT), and 8 with Graves' disease (GD) who were all positive for TgAb-IgGs. IgM binding to bovine serum albumin (BSA), keyhole limpet hemocyanin (KLH), and glucagon in ELISA was measured. Inhibition of TgAb-IgMs binding to coated Tg was evaluated by preincubating serum samples or IgG-depleted samples with soluble Tg.
RESULTS: TgAb-IgMs were positive in 10/16 patients with SAT, 2/11 with HT, and 1/8 with GD. TgAb-IgMs were higher in SAT (0.95; 0.42-1.13) (median; 25th-75th percentiles) than in HT (0.47; 0.45-0.51) and GD patients (0.35; 0.33-0.40) (P < .005 for both). IgM binding of SAT sera to BSA, KLH, and glucagon was significantly lower than Tg. Preincubation with soluble Tg reduced the binding of IgMs to coated Tg by 18.2% for serum samples and by 35.0% and 42.1% for 2 IgG-depleted samples. TgAb-IgM levels were inversely, although nonsignificantly, correlated with Tg concentrations.
CONCLUSIONS: Tg leak associated with thyroid injury induces the production of specific TgAb-IgMs, which, in turn, increases the clearance of Tg and might prevent the establishment of a persistent thyroid autoimmune response. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Graves’ disease; Hashimoto’s thyroiditis; IgM; subacute thyroiditis; thyroglobulin; thyroglobulin autoantibodies

Mesh:

Substances:

Year:  2020        PMID: 31996918     DOI: 10.1210/clinem/dgaa038

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Subacute Thyroiditis During the SARS-CoV-2 Pandemic.

Authors:  Alessandro Brancatella; Nicola Viola; Grazia Rutigliano; Daniele Sgrò; Ferruccio Santini; Francesco Latrofa
Journal:  J Endocr Soc       Date:  2021-07-28

2.  Subacute Thyroiditis After Sars-COV-2 Infection.

Authors:  Alessandro Brancatella; Debora Ricci; Nicola Viola; Daniele Sgrò; Ferruccio Santini; Francesco Latrofa
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

3.  Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.

Authors:  Qungang Chang; Jieming Zhang; Yaqian Wang; Hongqiang Li; Xin Du; Daohong Zuo; Detao Yin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-15       Impact factor: 6.055

4.  Case report: subacute thyroiditis after receiving SARS-CoV-2 vaccine, maybe not only adjuvants.

Authors:  Yizhou Huang; Xingyu Chen; Qing Wang; Xiaowei Lei; Lili Zhang
Journal:  Front Med (Lausanne)       Date:  2022-08-05

5.  Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection.

Authors:  Dimitra Argyro Vassiliadi; Ioannis Ilias; Maria Pratikaki; Edison Jahaj; Alice G Vassiliou; Maria Detsika; Kleio Ampelakiotou; Marina Koulenti; Konstantinos N Manolopoulos; Stamatis Tsipilis; Evdokia Gavrielatou; Aristidis Diamantopoulos; Alexandros Zacharis; Nicolaos Athanasiou; Stylianos Orfanos; Anastasia Kotanidou; Stylianos Tsagarakis; Ioanna Dimopoulou
Journal:  Endocr Connect       Date:  2021-06-17       Impact factor: 3.335

6.  The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection.

Authors:  Irene Campi; Ilaria Bulgarelli; Antonella Dubini; Giovanni Battista Perego; Elena Tortorici; Camilla Torlasco; Erminio Torresani; Lorenzo Rocco; Luca Persani; Laura Fugazzola
Journal:  Eur J Endocrinol       Date:  2021-05       Impact factor: 6.558

7.  Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade.

Authors:  Alessandro Brancatella; Isabella Lupi; Lucia Montanelli; Debora Ricci; Nicola Viola; Daniele Sgrò; Lucia Antonangeli; Chiara Sardella; Sandra Brogioni; Paolo Piaggi; Eleonora Molinaro; Francesca Bianchi; Michele Aragona; Andrea Antonuzzo; Andrea Sbrana; Maurizio Lucchesi; Antonio Chella; Alfredo Falcone; Stefano Del Prato; Rossella Elisei; Claudio Marcocci; Patrizio Caturegli; Ferruccio Santini; Francesco Latrofa
Journal:  J Endocr Soc       Date:  2021-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.